Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 Feb 15;148(4):579–580.

Familial defective apolipoprotein B-100: a cause of hypercholesterolemia and early coronary heart disease.

B A Nassar 1
PMCID: PMC1490544  PMID: 8431820

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232(4746):34–47. doi: 10.1126/science.3513311. [DOI] [PubMed] [Google Scholar]
  2. Illingworth D. R., Vakar F., Mahley R. W., Weisgraber K. H. Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100. Lancet. 1992 Mar 7;339(8793):598–600. doi: 10.1016/0140-6736(92)90875-4. [DOI] [PubMed] [Google Scholar]
  3. Innerarity T. L., Mahley R. W., Weisgraber K. H., Bersot T. P., Krauss R. M., Vega G. L., Grundy S. M., Friedl W., Davignon J., McCarthy B. J. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res. 1990 Aug;31(8):1337–1349. [PubMed] [Google Scholar]
  4. Ludwig E. H., Blackhart B. D., Pierotti V. R., Caiati L., Fortier C., Knott T., Scott J., Mahley R. W., Levy-Wilson B., McCarthy B. J. DNA sequence of the human apolipoprotein B gene. DNA. 1987 Aug;6(4):363–372. doi: 10.1089/dna.1987.6.363. [DOI] [PubMed] [Google Scholar]
  5. Maher V. M., Gallagher J. J., Thompson G. R., Myant N. B. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100. Atherosclerosis. 1991 Nov;91(1-2):73–76. doi: 10.1016/0021-9150(91)90188-9. [DOI] [PubMed] [Google Scholar]
  6. Milne R., Théolis R., Jr, Maurice R., Pease R. J., Weech P. K., Rassart E., Fruchart J. C., Scott J., Marcel Y. L. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J Biol Chem. 1989 Nov 25;264(33):19754–19760. [PubMed] [Google Scholar]
  7. Motti C., Funke H., Rust S., Dergunov A., Assmann G. Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100. Clin Chem. 1991 Oct;37(10 Pt 1):1762–1766. [PubMed] [Google Scholar]
  8. Schuster H., Rauh G., Kormann B., Hepp T., Humphries S., Keller C., Wolfram G., Zöllner N. Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich. Arteriosclerosis. 1990 Jul-Aug;10(4):577–581. doi: 10.1161/01.atv.10.4.577. [DOI] [PubMed] [Google Scholar]
  9. Tybjaerg-Hansen A., Gallagher J., Vincent J., Houlston R., Talmud P., Dunning A. M., Seed M., Hamsten A., Humphries S. E., Myant N. B. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis. 1990 Jan;80(3):235–242. doi: 10.1016/0021-9150(90)90031-d. [DOI] [PubMed] [Google Scholar]
  10. Tybjaerg-Hansen A., Humphries S. E. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis. 1992 Oct;96(2-3):91–107. doi: 10.1016/0021-9150(92)90056-m. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES